Financial Results

Company issued 43.86 million shares at $2.28 per share.

Funding to accelerate commercial equipment procurement amid China's export restrictions.

The agreement is non-dilutive and unsecured.

The company plans to raise $1.1 million through the offering.

Venus Concept Inc. received a decision to grant European Patent Number EP3542745.

Funding aimed at advancing innovative therapies and improving patient outcomes globally.